Results 191 to 200 of about 2,761,482 (311)

Magnetic resonance: in vivo tissue characterization of the testes in patients with carcinoma‐in‐situ of the testis and healthy subjects [PDF]

open access: bronze, 1987
C. Thomsen   +5 more
openalex   +1 more source

X‐ray controlled release strategy in cancer therapy

open access: yesBMEMat, EarlyView.
A comprehensive review on the design principles and current strategies of X‐ray stimulated release systems in cancer therapy, focusing on the X‐ray responsive functional groups and materials as well as discussing the advantages and current challenges of X‐ray controlled release systems in cancer therapy.
Yiling Ruan   +5 more
wiley   +1 more source

Carcinoma in situ specimen classification based on intermediate cell measurements [PDF]

open access: bronze, 1987
Michael W. Katzko   +3 more
openalex   +1 more source

In situ and early invasive bronchogenic carcinoma

open access: hybrid, 1970
Lewis B. Woolner   +4 more
openalex   +1 more source

Carcinoma in Situ of Contralateral Testis in Patients with Testicular Germ Cell Cancer: Study of 27 Cases in 500 Patients [PDF]

open access: green, 1987
Hans von der Maase   +8 more
openalex   +1 more source

Ductal carcinoma in situ

open access: yes, 2012
Henry Knipe, Garth Kruger
openaire   +1 more source

Novel molecular mechanisms of immune evasion in hepatocellular carcinoma: NSUN2‐mediated increase of SOAT2 RNA methylation

open access: yesCancer Communications, EarlyView.
Abstract Background Hepatocellular carcinoma (HCC) is a deadly malignancy known for its ability to evade immune surveillance. NOP2/Sun RNA methyltransferase family member 2 (NSUN2), an RNA methyltransferase involved in carcinogenesis, has been associated with immune evasion and energy metabolism reprogramming.
Jinhua Jiang   +6 more
wiley   +1 more source

Enhancing antitumor immunity through the combination of cholesterolized TLR7 agonist liposomes and radiotherapy: a role for IL‐1β and the inflammasome pathway

open access: yesCancer Communications, EarlyView.
Abstract Background Radiotherapy (RT) is a key treatment modality in cancer therapy, utilizing high‐energy radiation to directly kill tumor cells. Recent research has increasingly highlighted RT's potential to indirectly enhance antitumor immunity. However, this immune activation alone often fails to generate sustained systemic antitumor responses.
Xuejiao Han   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy